These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28424286)

  • 21. Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression.
    Selhorst P; Combrinck C; Ndabambi N; Ismail SD; Abrahams MR; Lacerda M; Samsunder N; Garrett N; Abdool Karim Q; Abdool Karim SS; Williamson C
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
    Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
    J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.
    Martins AN; Waheed AA; Ablan SD; Huang W; Newton A; Petropoulos CJ; Brindeiro RD; Freed EO
    J Virol; 2016 Jan; 90(2):768-79. PubMed ID: 26512081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness.
    Chopera DR; Cotton LA; Zawaira A; Mann JK; Ngandu NK; Ntale R; Carlson JM; Mlisana K; Woodman Z; de Assis Rosa D; Martin E; Miura T; Pereyra F; Walker BD; Gray CM; Martin DP; Ndung'u T; Brockman MA; Karim SA; Brumme ZL; Williamson C;
    J Virol; 2012 Dec; 86(24):13423-33. PubMed ID: 23015721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.
    Sacktor N; Nakasujja N; Skolasky RL; Rezapour M; Robertson K; Musisi S; Katabira E; Ronald A; Clifford DB; Laeyendecker O; Quinn TC
    Clin Infect Dis; 2009 Sep; 49(5):780-6. PubMed ID: 19622045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches.
    Lee GQ; Bangsberg DR; Mo T; Lachowski C; Brumme CJ; Zhang W; Lima VD; Boum Y; Mwebesa BB; Muzoora C; Andia I; Mbalibulha Y; Kembabazi A; Carroll R; Siedner MJ; Haberer JE; Mocello AR; Kigozi SH; Hunt PW; Martin JN; Harrigan PR
    AIDS; 2017 Nov; 31(17):2345-2354. PubMed ID: 28832407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection.
    Macharia GN; Yue L; Staller E; Dilernia D; Wilkins D; Song H; McGowan E; King D; Fast P; Imami N; Price MA; Sanders EJ; Hunter E; Gilmour J
    PLoS Pathog; 2020 Sep; 16(9):e1008853. PubMed ID: 32886726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1
    Kapaata A; Balinda SN; Xu R; Salazar MG; Herard K; Brooks K; Laban K; Hare J; Dilernia D; Kamali A; Ruzagira E; Mukasa F; Gilmour J; Salazar-Gonzalez JF; Yue L; Cotten M; Hunter E; Kaleebu P
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes.
    Louwagie J; Delwart EL; Mullins JI; McCutchan FE; Eddy G; Burke DS
    AIDS Res Hum Retroviruses; 1994 May; 10(5):561-7. PubMed ID: 7917518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individuals.
    Wright JK; Brumme ZL; Julg B; van der Stok M; Mncube Z; Gao X; Carlson JM; Goulder PJ; Walker BD; Brockman MA; Ndung'u T
    J Virol; 2012 Jan; 86(2):1273-6. PubMed ID: 22090116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization.
    Cornelissen M; Kampinga G; Zorgdrager F; Goudsmit J
    J Virol; 1996 Nov; 70(11):8209-12. PubMed ID: 8892955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes.
    Renjifo B; Fawzi W; Mwakagile D; Hunter D; Msamanga G; Spiegelman D; Garland M; Kagoma C; Kim A; Chaplin B; Hertzmark E; Essex M
    J Hum Virol; 2001; 4(1):16-25. PubMed ID: 11213929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden.
    Leitner T; Escanilla D; Marquina S; Wahlberg J; Broström C; Hansson HB; Uhlén M; Albert J
    Virology; 1995 May; 209(1):136-46. PubMed ID: 7747463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: further evidence of broad HIV type 1 genetic diversity.
    Zhong P; BUrda S; Konings F; Urbanski M; Ma L; Zekeng L; Ewane L; Agyingi L; Agwara M; Saa ; Afane ZE; Kinge T; Zolla-Pazner S; Nyambi P
    AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1167-78. PubMed ID: 14717120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection.
    de Azevedo SSD; Delatorre E; Côrtes FH; Hoagland B; Grinsztejn B; Veloso VG; Souza TML; Morgado MG; Bello G
    AIDS; 2019 Mar; 33(3):399-410. PubMed ID: 30531316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
    Saina MC; Bi X; Lihana R; Lwembe R; Ishizaki A; Panikulam A; Palakudy T; Musoke R; Owens M; Songok EM; Ichimura H
    PLoS One; 2015; 10(8):e0137140. PubMed ID: 26317223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid identification of human immunodeficiency virus type 1 CRF01_AE and BC recombinants by subtype-specific PCR.
    Luo H; Su QJ; Shao YM; Xing H; Chen J; Liu W; Zhang ZY; Zang N; Xiao X; Liang H
    J Virol Methods; 2011 Feb; 171(2):339-44. PubMed ID: 21126539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug susceptibility and replication capacity of a rare HIV-1 subtype C protease hinge region variant.
    Zondagh J; Basson AE; Achilonu I; Morris L; Dirr HW; Sayed Y
    Antivir Ther; 2019; 24(5):333-342. PubMed ID: 30958309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.
    Kahle E; Campbell M; Lingappa J; Donnell D; Celum C; Ondondo R; Mujugira A; Fife K; Mugo N; Kapiga S; Mullins JI; Baeten JM;
    AIDS; 2014 Jan; 28(2):235-43. PubMed ID: 24413311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G.
    Konings FA; Burda ST; Urbanski MM; Zhong P; Nadas A; Nyambi PN
    J Med Virol; 2006 May; 78(5):523-34. PubMed ID: 16555291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.